Regenerex Pharma (RGPX) Return on Assets (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Return on Assets data on file, last reported at 0.04% in Q3 2025.

• Return on Assets for Q3 2025 came in at 0.04%, down 2.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.04% (down 2.0% YoY), and the FY2025 annual result was 0.02%, up 7.0% from the prior year.
• Return on Assets retreated to 0.04% in Q3 2025 per RGPX's latest filing, from 0.03% in the prior quarter.
• Over five years, Return on Assets peaked at 0.01% in Q1 2021 and troughed at 0.26% in Q1 2023.
• A 5-year average of 0.08% and a median of 0.04% in 2025 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2022 and 2024: Return on Assets dropped 13 bps in 2022, then rose 21 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.12% in 2021, then sank by 48 bps to 0.18% in 2022, then surged by 79 bps to 0.04% in 2023, then soared by 37 bps to 0.02% in 2024, then tumbled by 91 bps to 0.04% in 2025.
• Business Quant data shows RGPX's Return on Assets at 0.04% in Q3 2025, 0.03% in Q2 2025, and 0.03% in Q1 2025.